SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-036192
Filing Date
2022-03-21
Accepted
2022-03-21 17:27:13
Documents
12
Period of Report
2022-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210014d1_8k.htm   iXBRL 8-K 33815
  Complete submission text file 0001104659-22-036192.txt   208439

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20220318.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220318_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220318_pre.xml EX-101.PRE 22587
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2210014d1_8k_htm.xml XML 3604
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 22756514
SIC: 2834 Pharmaceutical Preparations